Mirum Pharmaceuticals, Inc. MIRM Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s shares (diluted)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported shares (diluted) of 58.9M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s shares (diluted) increased by 20.4% year-over-year, from 48.9M to 58.9M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s shares (diluted) has grown at a 14.2% compound annual growth rate (CAGR), from 121.1M to 205.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.